Paip1 inhibitors belong to a specialized class of chemical compounds designed to modulate the activity of Poly(A)-binding protein-interacting protein 1 (Paip1). Paip1 is a key regulatory protein involved in the control of mRNA translation and stability, exerting its influence through interactions with the Poly(A) tail of mRNA molecules. The Poly(A) tail plays a crucial role in mRNA stability and translation initiation, making Paip1 a pivotal player in the intricate machinery of gene expression. Paip1 inhibitors are meticulously designed molecules that selectively target Paip1, aiming to either block or modulate its function within the cellular context.
Paip1 inhibitors allows for a range of mechanisms to disrupt Paip1 activity. These compounds may operate through competitive binding to the Poly(A) tail binding site on Paip1, preventing its interaction with mRNA and subsequently influencing translation initiation. Alternatively, Paip1 inhibitors may act allosterically, inducing conformational changes in the protein that hinder its ability to engage with mRNA effectively. The development and exploration of Paip1 inhibitors provide a valuable avenue for researchers seeking to unravel the intricacies of post-transcriptional gene regulation. Understanding the precise mechanisms by which these inhibitors modulate Paip1 function holds promise for advancing our knowledge of fundamental cellular processes, shedding light on the complex orchestration of events governing gene expression at the mRNA level.
SEE ALSO...
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Inhibits mTOR, which indirectly affects translation initiation factors, potentially impacting PAIP1 function. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
PI3K inhibitor, alters signaling pathways that could influence PAIP1's role in translation initiation. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
Another PI3K inhibitor, which may indirectly modulate the activity of proteins like PAIP1. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
p38 MAPK inhibitor, potentially altering the cellular context in which PAIP1 operates. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
JNK inhibitor, may modify the phosphorylation status of factors interacting with PAIP1. | ||||||
Lactacystin | 133343-34-7 | sc-3575 sc-3575A | 200 µg 1 mg | $165.00 $575.00 | 60 | |
Specific proteasome inhibitor, similar in function to MG132, affecting protein turnover related to PAIP1. | ||||||
5-Iodotubercidin | 24386-93-4 | sc-3531 sc-3531A | 1 mg 5 mg | $150.00 $455.00 | 20 | |
Adenosine kinase inhibitor, may indirectly affect PAIP1 by altering adenosine monophosphate levels. | ||||||
Roscovitine | 186692-46-6 | sc-24002 sc-24002A | 1 mg 5 mg | $92.00 $260.00 | 42 | |
CDK inhibitor, could indirectly affect translation initiation by altering cell cycle-related processes. | ||||||
PF 4708671 | 1255517-76-0 | sc-361288 sc-361288A | 10 mg 50 mg | $175.00 $700.00 | 9 | |
S6K1 inhibitor, might indirectly affect PAIP1 by modulating downstream targets of mTOR signaling. |